Signaling Pathway | Gene Name | Molecular Function | F344_Saline (Mean ± S.E.M) | HIV-1Tg_Saline (Mean ± S.E.M) | Ratio (HIV-1Tg/F344) Saline | P Value |
---|---|---|---|---|---|---|
Hippocampus | Â | Â | Â | Â | Â | Â |
Metabotropic glutamate receptor mediated PLC/IP3-dependent calcium signaling | Grm5 | Metabotropic glutamate receptor activity | 4.4E-02 ± 3.4E-03 | 6.0E-02 ± 2.1E-03 | 1.36 | 0.004 |
Plcb4 | Phospholipase C activity | 2.4E-02 ± 2.2E-04 | 3.9E-04 ± 3.8E-04 | 1.63 | 0.005 | |
Itpr3 | Calcium ion transmembrane transporter activity | 7.3E-04 ± 1.5E-04 | 1.3E-03 ± 1.5E-04 | 1.78 | 0.02 | |
Ca+2/calmodulin-dependent protein kinase signaling | Cacna1i | Voltage-gated calcium channel activity | 2.0E-03 ± 3.6E-04 | 3.0E-03 ± 2.1E-04 | 1.5 | 0.04 |
Camk4 | Calmodulin dependent protein kinase activity | 3.3E-02 ± 1.1E-03 | 3.9E-02 ± 1.7E-03 | 1.2 | 0.02 | |
Calm4 | Calcium ion binding | 2.6E-03 ± 3.1E-04 | 3.7E-03 ± 2.5E-04 | 1.42 | 0.03 | |
CREB signaling | Creb-2 (Atf4) | Transcription factor activity | 8.0E-03 ± 2.8E-04 | 1.2E-02 ± 4.4E-04 | 1.57 | 0.01 |
Kinase signaling | Akt1 (PKB) | Protein kinase activity | 2.7E-02 ± 2.4E-03 | 4.0E-02 ± 2.6E-03 | 1.48 | 0.006 |
Mapk3 | Mitogen activated kinase activity | 9.6E-02 ± 8.0E-03 | 7.2E-02 ± 6.5E-03 | 0.74 | 0.03 | |
Adcy8 | Adenylate cyclase activity | 7.6E-03 ± 4.2E-04 | 6.1E-03 ± 6.0E-04 | 0.80 | 0.033 | |
Immediate early response gene | Arc | Actin binding | 1.2E-02 ± 2.0E-02 | 6.2E-03 ± 1.2E-03 | 0.49 | 0.03 |
Bdnf | Growth factor activity | 4.2E-04 ± 5.0E-05 | 2.3E-04 ± 7.1E-05 | 0.56 | 0.02 | |
Jun-b | Transcription factor activity | 1.5E-02 ± 2.2E-03 | 9.9E-03 ± 7.5E-04 | 0.63 | 0.03 | |
Ngf | Growth factor activity | 6.5E-03 ± 4.7E-04 | 4.9E-03 ± 4.8E-04 | 0.75 | 0.01 | |
Postsynaptic organization of synapse | Gria1 | Glutamate receptor activity | 2.2E-01 ± 2.4E-02 | 1.5E-01 ± 1.7E-02 | 0.69 | 0.006 |
Adam10 | Metallopeptidase activity | 2.6E-02 ± 1.6E-03 | 1.9E-01 ± 2.0E-03 | 0.74 | 0.04 | |
Prefrontal Cortex | Â | Â | Â | Â | Â | |
Metabotropic glutamate receptor mediated PLC/IP3-dependent calcium signaling | Grm1 | Metabotropic glutamate receptor activity | 5.6E-02 ± 8.0E-03 | 3.3E-02 ± 5.5E-03 | 0.58 | 0.03 |
Plcb4 | Phospholipase C activity | 2.0E-02 ± 1.2E-04 | 1.4E-02 ± 5.8E-04 | 0.70 | 0.002 | |
Itpr1 | Calcium Ion transmembrane transporter activity | 7.0E-03 ± 7.9E-04 | 5.0E-03 ± 4.9E-04 | 0.71 | 0.04 | |
Itrp2 | Calcium Ion transmembrane transporter activity | 1.5E-01 ± 1.2E-02 | 1.2E-01 ± 1.5E-03 | 0.81 | 0.03 | |
Ca+2/calmodulin-dependent kinase signaling | Cacna1g | Voltage–gated calcium channel activity | 2.6E-02 ± 2.4E-03 | 1.7E-02 ± 1.0E-03 | 0.68 | 0.01 |
Camk2g | Calmodulin-dependent kinase activity | 2.6E-02 ± 1.8E-03 | 2.0E-02 ± 3.5E-04 | 0.79 | 0.02 | |
Cdh2 | Calcium ion binding activity | 6.9E-02 ± 1.2E-02 | 3.2E-02 ± 2.5E-03 | 0.46 | 0.01 | |
Kinase signaling | Map2k1 | MAP kinase activity | 1.2E-01 ± 1.0E-02 | 9.2E-02 ± 4.2E-03 | 0.73 | 0.02 |
Mapk3 | MAP kinase activity | 6.6E-02 ± 3.9E-03 | 5.4E-02 ± 2.1E-03 | 0.81 | 0.03 | |
Raf1 | MAP kinase kinase activity | 2.0E-02 ± 7.0E-04 | 1.6E-02 ± 1.0E-03 | 0.82 | 0.03 | |
Prkacb | Protein kinase A activity | 1.9E-02 ± 1.3E-03 | 1.5E-02 ± 7.5E-04 | 0.79 | 0.04 | |
Akt1 | Akt kinase activity | 4.2E-02 ± 2.6E-03 | 3.4E-02 ± 1.6E-03 | 0.80 | 0.03 | |
JNK1 | C-Jun N-terminal protein kinase | 1.3E-01 ± 3.4E-03 | 1.9E-01 ± 4.3E-03 | 1.46 | 0.02 | |
Inflammation-mediated neurodegenera-tive signaling | Il-6 | Cytokine activity | 1.5E-04 ± 1.5E-05 | 7.4E-05 ± 9.8E-06 | 0.48 | 0.002 |
Ccl2 | Chemokine activity | 2.0E-04 ± 2.4E-05 | 1.2E-04 ± 1.2E-05 | 0.61 | 0.02 | |
Gabra5 | GABA-A receptor activity | 4.3E-02 ± 2.1E-03 | 3.3E-02 ± 2.5E-03 | 0.77 | 0.02 | |
Postsynaptic density formation | Gria1 | Glutamate receptor activity | 8.4E-02 ± 4.5E-03 | 6.6E-02 ± 1.0E-03 | 0.79 | 0.02 |
Amygdala | Â | Â | Â | Â | Â | Â |
Ionotropic glutamate receptor- mediated Ca+2 signaling | Grin1 | Ionotropic glutamate receptor activity | 1.4E-01 ± 7.1E-01 | 1.0E-01 ± 8.3E-03 | 0.76 | 0.01 |
Ca+2/calmodulin-dependent kinase signaling | Cacna1g | Voltage–gated calcium channel activity | 2.7E-01 ± 2.4E-03 | 1.7E-02 ± 5.0E-04 | 0.63 | 0.006 |
Calm2 | Calcium ion binding | 1.0 ± 7.5E-02 | 7.4E-01 ± 2.8E-02 | 0.71 | 0.01 | |
Kinase signaling | Mapk1 | MAP kinase activity | 2.7E-01 ± 2.2E-02 | 1.7E-01 ± 1.0E-03 | 0.61 | 0.02 |
Mapk3 | MAP kinase activity | 9.3E-02 ± 9.4E-03 | 6.2E-02 ± 2.9E-03 | 0.67 | 0.01 | |
Raf1 | MAP kinase kinase kinase activity | 2.5E-02 ± 1.5E-03 | 1.7E-02 ± 8.6E-04 | 0.69 | 0.02 | |
Immediate early gene response | Ntrk2 | Growth factor activity | 4.3E-03 ± 5.7E-04 | 2.5E-03 ± 2.1E-04 | 0.57 | 0.01 |
Junb | Transcription factor activity | 1.5E-02 ± 2.2E-03 | 9.9E-03 ± 7.6E-04 | 0.63 | 0.03 | |
Postsynaptic organization of synapse | Gria3 | Ionotropic glutamate receptor activity (AMPA) | 4.1E-02 ± 3.5E-3 | 2.6E-02 ± 2.7E-03 | 0.63 | 0.02 |
Adam10 | Metallopeptidase activity | 2.6E-02 ± 1.6E-03 | 1.9E-02 ± 2.0E-03 | 0.74 | 0.04 | |
Gria1 | Ionotropic glutamate receptor activity (AMPA) | 1.3E-01 ± 3.5E-03 | 1.0E-01 ± 5.3E-03 | 0.83 | 0.02 | |
Dlg4 | Scaffold protein binding | 2.5E-01 ± 2.9E-01 | 1.2E-01 ± 6.4E-03 | 0.46 | 0.003 |